All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Compounded Semaglutide Results After 9 Months: What to Expect

After 9 months on compounded semaglutide, most patients lose 22 to 38 pounds. Here is a cost-effective treatment timeline with clinical data and guidance.

By Dr. Michael Torres, MD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Michael Torres, MD · Reviewed by Dr. David Kim, MD, FACE

Compounded Semaglutide Results After 9 Months: What to Expect custom 2026 header image for GLP-1 Weight Loss
Custom header image for Compounded Semaglutide Results After 9 Months: What to Expect, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Compounded Semaglutide Results After 9 Months: What to Expect

After 9 months on compounded semaglutide, most patients lose 22 to 38 pounds. Here is a cost-effective treatment timeline with clinical data and guidance.

Short answer

After 9 months on compounded semaglutide, most patients lose 22 to 38 pounds. Here is a cost-effective treatment timeline with clinical data and guidance.

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

After 9 months on compounded semaglutide, most patients lose 22 to 38 pounds. Here is a cost-effective treatment timeline with clinical data and guidance.

Nine months of compounded semaglutide therapy delivers results that prove you don't need the most expensive brand-name product to achieve meaningful weight loss. Patients researching compounded semaglutide results after 9 months can expect a total weight loss of 22 to 38 pounds, representing roughly 10% to 15% of starting body weight .

Nine-Month Results Data

Metric Typical Range at 9 Months
Total weight loss 22 to 38 pounds
Body weight percentage 10% to 15%
Waist circumference 4 to 6.5 inches lost
Blood pressure 7 to 14 mmHg systolic decrease
Fasting glucose 20 to 45 mg/dL decrease
Current dose 2.0 to 2.4 mg weekly

The Cost Story at Nine Months

Nine months of treatment is where the financial advantage of compounded semaglutide becomes most meaningful From $299: For a complete cost breakdown, see our cheapest semaglutide options.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Compounded Semaglutide Results After 9 Months: What to Expect
  • Nine months of brand-name Wegovy without insurance: approximately $10,800 to $15,300
  • Nine months of compounded semaglutide through FormBlends: dramatically less
  • Same active ingredient, same mechanism, comparable results
  • The savings over nine months can amount to thousands of dollars

This cost advantage is what makes long-term treatment feasible for many patients. At FormBlends, we believe financial constraints shouldn't prevent anyone from accessing effective weight loss treatment FormBlends pricing.

Where You Stand at Nine Months

At this stage, your treatment is well-established :

Get compounded semaglutide from $99/mo

Free provider review, personalized dosing, and ongoing support included.

Start Free Assessment →
  • Dose: Most patients are stable at 2.0 to 2.4 mg weekly.
  • Appetite: Well-controlled and predictable. Eating less feels natural.
  • Weight loss trend: Decelerating, with monthly loss of 1 to 3 pounds.
  • Side effects: Minimal at stable doses.
  • Health improvements: Blood pressure, blood sugar, lipids, and inflammation markers all at improved levels.

Compounded vs. Brand at the 9-Month Mark

Patients sometimes wonder if they should switch to brand-name Wegovy at this stage. Consider:

  • If compounded semaglutide is working well: There's no clinical reason to switch. The active ingredient is identical.
  • If you want the convenience of a prefilled pen: Wegovy pens are easier to use than vial-and-syringe preparation.
  • If insurance now covers Wegovy: It may make financial sense to switch.
  • If you want to continue affordably: Stay with compounded semaglutide .

Planning for Months 9 to 12

  • Lab work. Full panel including metabolic, lipids, CBC, vitamins, and thyroid.
  • Body composition assessment. Measure fat, muscle, and bone density changes.
  • Dose improvement trial. Some patients can maintain at a lower dose, further reducing monthly costs.
  • Long-term strategy. Plan for year two of treatment or a structured maintenance approach FormBlends telehealth consultation.

Frequently Asked Questions

Are 9-month compounded semaglutide results comparable to Wegovy?

Yes, when dosed equivalently. The active active ingredient is in the same class, and results at matching doses are comparable .

Should I continue past 9 months?

Most patients benefit from continuing. Stopping typically leads to weight regain. If you're near your goal weight, your provider may trial a lower maintenance dose.

Can I reduce my dose to save more money?

Possibly. Some patients maintain their weight at 1.7 or even 1.0 mg after reaching their goal. Your provider can help trial a dose reduction while monitoring for regain.

How long will compounded semaglutide remain available?

Compounded semaglutide availability depends on FDA regulations around drug shortages. FormBlends monitors this closely and will communicate any changes that affect your treatment .

What if I want to switch to tirzepatide for more weight loss?

Switching from semaglutide to compounded tirzepatide is straightforward. Your provider will determine the appropriate starting dose. Many patients who have plateaued on semaglutide see additional weight loss on tirzepatide semaglutide vs tirzepatide comparison.

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Wegovy evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Compounded Semaglutide Results After 9 Months: What to Expect, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide Results After 9 Months: What to Expect is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

FormBlends Editorial Context

Reviewed May 14, 2026

After 9 months on compounded semaglutide, most patients lose 22 to 38 pounds. Here is a cost-effective treatment timeline with clinical data and guidance. Use "Compounded Semaglutide Results After 9 Months: What to Expect" to make the conversation more specific before you choose a provider, product, or next step. The page leans into patient education and clinical context and the details behind semaglutide, cost and coverage, provider access, safety and pharmacy quality. Because this article has 6 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. The safest takeaway is a better checklist for clinician review, not a do-it-yourself medical decision.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify total monthly cost, refill timing, dose escalation pricing, and what is included before paying.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Compounded Semaglutide Results After 9 Months

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, compounded so the article stays close to the question behind "Compounded Semaglutide Results After 9 Months".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Compounded Semaglutide Results After 9 Months from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Compounded Semaglutide Results After 9 Months custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Compounded Semaglutide Results After 9 Months, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Compounded Semaglutide Results After 9 Months, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. Michael Torres, MD

Endocrinologist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.